ISR Articles

51. Decision-making Responsibilities When Outsourcing Late-Phase Studies

    A look at which departments at sponsor organizations are involved in the decision-making process and how much decision-making responsibility each department has for outsourcing various late-phase study activities.

52. Can CROs Rise To The Patient Access & Recruitment Challenge?

    Patient recruitment and retention comes with its own sets of unique challenges to overcome. But how does it impact which CROs sponsors are choosing to run their studies? Explore the answer to this question in this article.

53. Rare Disease Studies: A Comfortable Patient Is A Retained Patient

    Challenges are baked into rare disease studies compared to typical studies: very small patient pools, specialized protocols, difficult-to-define endpoints, often very sick patients, and the predicament of high cost versus low volume. Discover the secret weapons to maintaining patient retention despite these challenges.

54. Industry Trends In Clinical Development Technology

    As electronic data sources become embedded in the clinical development process, discover how systems, processes, files, storage, and approvals are moving away from paper and becoming dependent on technology applications.

55. The Quest To Improve Efficiency In Site Contract And Budget Negotiations

    It will come as a surprise to no one that site start up is a challenging part of the clinical trial process. Various pieces of research on this topic have put the length of site start up in the ballpark of 7 to 10 months. Delve into the research that states the most problematic step of site start up is site contract and budget negotiations…by a mile.

56. Can Integrated Service Providers Help Simplify Complex Clinical Trial Logistics?

    Various factors are causing the distribution of clinical trial materials to become more complex, and sponsors looking to engage a third-party logistics provider have multiple options, each with benefits and drawbacks. Data from Industry Standard Research’s Clinical Logistics Market Dynamics and Service Provider Benchmarking report will educate readers about current usage patterns and preferences for outsourced clinical logistics providers as well as what the future may bring.

57. Top 5 Selection Attributes For Outsourced eTMF Services

    In a recent survey, ISR asked outsourcers of eTMF services about their thoughts on 22 selection qualities that drive eTMF provider selection. Overall ease of use tops the list as the most important driver for selection (25%), followed by Integration with other systems (17%), Data security (12%), Auditability (10%), and Systems performance/uptime (5%). 

58. How Will mHealth Benefit Clinical Trials?

    In the past 50 years, since the onset of the digital age, the world has been transformed by technology. In the last decade, see how technology has disrupted the way we shop, communicate, and get from point A to point B.

59. Hybrid Trials Are Here To Stay

    The rapid uptake of trials in which patients participate from home has been a game-changer for continuing clinical research in the face of the COVID-19 pandemic. Individuals with recent experience conducting hybrid trials were asked to share their outlook on hybrid trials’ place in the biopharmaceutical industry over the next three years.

60. The Impact Of mHealth Technologies On Clinical Trial Spending

    In Q3, 2018 ISR asked 48 users of mHealth technologies whether they anticipate changes in their companies’ clinical trials expenditure due to incorporating mHealth technologies into clinical trials. The data show that more than four-out-of-five respondents believe there will be an increase in spending in the coming 12 months.